Neurology. Diagnostics for Multiple Sclerosis.
Details
Metabolite Constellations. For MS Progression Monitoring.
(in dev.) In collaboration with Oxford University, numares is evaluating a metabolite constellation to monitor relapsing remitting multiple sclerosis (RRMS) patients for the transition to the progressive form (secondary progressive MS, SPMS). The transition to SPMS can only be diagnosed retrospectively since there is no diagnostic test currently available. The serum-based test would support the monitoring of multiple sclerosis progression in clinical routine and enable early therapy intervention.
Technology. The AXINON® System.
The application will be developed and provided for the AXINON® System which produces high-quality, standardized NMR spectra based on numares’ Magnetic Group Signaling (MGS®) technology.
The combination of MGS® with the AXINON® technology platform allows for spectral analysis with highly-reproducible results. The system is easy to use requiring minimal operator interaction. The test system is fast and efficient with automation capabilities allowing short hands-on-time and high walk-away capability.
To date, more than 2 million tests have been performed worldwide using the numares’ technology platform.
Customer reviews
No reviews were found for Neurology. Diagnostics for Multiple Sclerosis.. Be the first to review!